Preclinical Assessment of an Engineered HMGB1 Protein as a Novel Companion Therapy for Muscular Dystrophies

NCT07745218 · clinicaltrials.gov ↗

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)

Sponsor

IRCCS San Raffaele